Driving clinical
research forward

Our mission is to accelerate clinical research to bring life-changing therapies to patients sooner, transforming care through expertise and proven results.

Explore careers

Hear our story

Iterative Health was founded in 2017 with a clear vision: to tackle the gaps in healthcare and ensure patients get the treatments they need, when they need them. We imagine a future where clinical research can move faster, smarter, and more effectively to accelerate the delivery of innovative therapies that advance care.

Today, we bring that vision to life by partnering with providers and study sponsors to strengthen the infrastructure of clinical research and bring novel therapies to market faster.

By combining deep industry knowledge, operational excellence, and cutting-edge technology, we’re increasing access to research within the community care setting, and accelerating the advancement of new therapies for patients.

About Iterative Health

Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes. By combining deep expertise in clinical trials with cutting-edge AI, we empower research teams and study sponsors to expand and expedite access to novel therapeutics for patients in need. Today, Iterative Health is based in Cambridge, Massachusetts, and New York City with 250+ employees world-wide.

Our Team

Meet the people guiding our vision, culture, and impact

Executive Team

Jonathan Ng, MBBS

Founder / CEO

Bill Kayser

President & Chief Financial Officer

Julie Chang

General Manager, Cardiology

Dana Feuchtbaum

Chief Operating Officer

Laura Mantell

SVP, Partnerships

Daniel Wang

SVP, Finance & Operations

Management Team

Laurent Peyrin-Biroulet

EU Site Network Lead

Nadege Gunn, MD, CPI, DABOM, FAASLD

Chief Medical Officer, Hepatology & Obesity

Haig Soghigian

SVP, Professional Services

Matt Morris

VP, Corporate Development

Sloane Allebes Phillips

VP, Chief of Staff to
Chief Operating Officer

Charles C. Owen, Jr., MD, MBA, FACP, AGAF

VP, GI Medical

Mark R. Molenda, RPh

VP, Trials Partnerships

Matthew Ferreira

VP, Engineering

Michael Fives

VP, Product

Jedd Lucas

VP, People

Constantin Claussen

VP, Head of Ex-US Markets

Karishma Ramakrishnan

Senior Director, Program Management

Kim Baker

Director, Marketing

Dhara Sheth

Counsel, Director, Legal & Risk

Scientific Team

David Rubin, MD

Iterative Health IBD Chair
Chief, Section of Gastroenterology
University of Chicago, IL

Polina Golland, PhD

Iterative Health AI Chair
Professor, EECS & PI, MIT CSAIL Massachusetts Institute of Technology

Aasma Shaukat, MD, MPH

Iterative Health General Endoscopy Chair
Robert M. and Mary H. Glickman
Professor of Medicine and Population
Health, Director of Outcomes Research
NYU Langone, New York, NY

PI Leadership

Casey Chapman, MD

Chief Medical Officer
Principal Investigator,
Gastroenterology
GI Alliance

G. Aaron DuVall, MD

Principal Investigator,
Gastroenterology
Tyler Research Institute

Ziad H. Younes, MD

Principal Investigator,
Gastroenterology
Gastro One | One GI

Our Values: G.R.I.T.

At Iterative Health, collaboration, curiosity, and compassion drive everything we do;
celebrating learning, valuing diverse perspectives, and supporting each other
because meaningful progress only happens together.

Growth

We rise to the challenge, learn, adapt, and excel, face obstacles head-on and push forward even when it’s tough

Responsibility

We think and act like owners, taking pride in our work and holding ourselves and each other to high standards

Impact

We solve problems by focusing on impactful work and reflecting, improving, and repeating

Team

We win as a team, elevating each other because no one succeeds alone, and together we achieve more

Our Investors

Investment from top-tier firms and strategic partners
fuels our growth, technology, and industry leadership

Ready to make a difference
in clinical research?

Visit our Careers page to explore a variety of opportunities where you can grow professionally, make a real impact in advancing clinical research, and join a collaborative team dedicated to bringing innovative therapies to patients faster.